Covid-19 Vaccine
![BioNTech mpox vaccine, CEPI 100 Days Mission, mRNA orthopoxvirus vaccine, BNT166 phase 1/2 trial, CEPI funding BioNTech, mpox symptoms sculptures, Moderna mpox vaccine,](https://pharmtales.com/wp-content/uploads/2023/09/CEPI-funds-BioNTechs-mRNA-based-mpox-vaccine-trial-with-90-million.jpg)
CEPI funds BioNTech’s mRNA-based mpox vaccine trial with $90 million
BioNTech, the German biotech renowned for its groundbreaking mRNA COVID-19 vaccine, is embarking on clinical trials for an mRNA vaccine ...
![Moderna, Pfizer, COVID-19 Vaccine, mRNA vaccines, Alnylam Pharmaceuticals, CureVac, BioNTech, Patent infringement](https://pharmtales.com/wp-content/uploads/2023/08/Legal-Engagements-Amid-Scientific-Advancements_-Alnylams-Ongoing-Interplay-with-Moderna.jpg)
Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna
In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...
![How COVID-19 Vaccine Makers are Updating Their Shots to Fight the Virus](https://pharmtales.com/wp-content/uploads/2023/08/COVID-19-Vaccine-Makers-Prepare-for-Private-Market-Launches-Amid-Evolving-Variants.jpg)
COVID-19 Vaccine Makers Prepare for Private-Market Launches Amid Evolving Variants
Following a decline in demand for COVID-19 vaccines, prominent biopharmaceutical companies are gearing up for private-market launches this upcoming fall. ...
![Moderna Eyes Private COVID Market and RSV Launch as Sales Drop](https://pharmtales.com/wp-content/uploads/2023/08/Moderna-finds-promise-in-the-private-COVID-vaccination-market-and-the-debut-of-RSV-as-sales-plummet.jpg)
Moderna finds promise in the private COVID vaccination market and the debut of RSV as sales plummet
Source – Fiercepharma As Moderna continues its operations beyond the pandemic, the biotech firm has increased its revenue projection for ...
![Moderna Files Two New Patent Lawsuits Against mRNA Competitors Pfizer and BioNTech](https://pharmtales.com/wp-content/uploads/2023/07/Moderna-Files-Two-New-Patent-Lawsuits-Against-mRNA-Competitors-Pfizer-and-BioNTech.jpg)
Moderna Files Two New Patent Lawsuits Against mRNA Competitors Pfizer and BioNTech
In the ongoing patent disputes surrounding COVID-19 vaccines, Moderna has expanded its legal battle against Pfizer and BioNTech by filing ...
![Novavax's Covid vaccine receives a unanimous EU approval](https://pharmtales.com/wp-content/uploads/2023/07/Novavaxs-Covid-vaccine-receives-a-unanimous-EU-approval.jpg)
Novavax’s Covid vaccine receives a unanimous EU approval
Source – Novavax Novavax received full Marketing Authorization (MA) from the European Commission for its COVID-19 vaccine, Nuvaxovid (NVX-CoV2373). This ...
![For its updated Covid-19 vaccine, Moderna submits a regulatory application to the European Medicines Agency](https://pharmtales.com/wp-content/uploads/2023/07/For-its-updated-Covid-19-vaccine-Moderna-submits-a-regulatory-application-to-the-European-Medicines-Agency.jpg)
For its updated Covid-19 vaccine, Moderna submits a regulatory application to the European Medicines Agency
Source – Moderna On July 3, 2023 Moderna announced the submission of a regulatory application to the European Medicines Agency ...